Ligand validation:7M0F

BML: 4-BROMOPHENOL

BML is a Ligand Of Interest in 7M0F designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7M0F_BML_A_202	94%	70%	0.09	0.988	0.66	0.5	-	-	2	0	100%	0.82
7M0F_BML_B_202	89%	74%	0.11	0.988	0.56	0.47	-	-	1	0	100%	0.73
3LB2_BML_A_191	86%	71%	0.108	0.978	0.54	0.59	-	-	2	0	100%	0.82
4HSX_BML_B_203	46%	1%	0.2	0.937	3.72	3.74	3	6	4	0	100%	0.4
3OK5_BML_A_138	18%	73%	0.291	0.878	0.42	0.61	-	-	1	0	100%	0.225
3O7N_BML_B_192	17%	60%	0.318	0.902	0.48	1.05	-	1	0	0	100%	0.28
3RMK_BML_D_496	95%	76%	0.084	0.987	0.47	0.47	-	-	5	0	100%	0.7
1XU3_BML_B_1293	90%	2%	0.1	0.984	3.58	3.25	6	5	0	0	100%	1
1T0S_BML_B_331	87%	2%	0.099	0.971	3.63	3.31	5	5	0	0	100%	1
5M8U_BML_A_512	80%	98%	0.124	0.974	0.09	0.18	-	-	3	0	100%	0.66

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.